StockData
Tenax Therapeutics, Inc. logo

Tenax Therapeutics, Inc. (TENX) shareholders

TENXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$1.42−0.06 (-4.05%)

Close on Nov 17, 2026Market cap $53.14MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
81.1%
30M of 37M shares
Institutional holders
111
45 new, 13 sold out
Net institutional buying
10M
In Q2 2026
Insider trades, 12 months
24 buys · 0 sales
Net bought $6.54M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
ADAR1 Capital Management, LLC
Joint filing with Daniel Schneeberger (14.00%)
5,257,38914.00%13G (passive)Aug 31, 2026
FMR LLC
Joint filing with Abigail P. Johnson (14.90%)
3,942,37314.90%13G (passive)Jun 30, 2026
Vivo Opportunity Fund Holdings, L.P.
Joint filing with Vivo Opportunity, LLC (9.00%)
3,458,3279.00%13G (passive) amendmentJun 30, 2026
Bvf Partners L P/Il
Joint filing with Bvf Inc/Il (9.99%), Lampert Mark N (9.99%) and 3 more
3,110,3639.99%13G (passive) amendmentJun 30, 2026
Roderick Wong
Joint filing with RTW Investments, LP (9.90%)
2,866,6549.90%13G (passive) amendmentJun 30, 2026
BlackRock, Inc.2,804,7887.50%13G (passive) amendmentSep 30, 2026
Sphera Global Healthcare GP Ltd.
Joint filing with Sphera Funds Management Ltd. (7.09%), Sphera Global Healthcare Management LP (7.09%)
2,663,2967.09%13G (passive) amendmentSep 30, 2026
ING Capital Markets LLC
Joint filing with ING Groep N.V. (7.05%)
2,639,6667.05%13G (passive)Aug 19, 2026
Ryan Wilder
Joint filing with Vestal Point Capital, LP (9.90%)
2,470,0969.90%13G (passive)Sep 30, 2024
Kevin Pyun
Joint filing with Dellora Investments LP (6.40%), Dellora Investments Master Fund LP (5.50%)
2,400,0006.40%13G (passive) amendmentOct 2, 2026
Bong Y. Koh
Joint filing with Nimish Shah (9.90%), VHCP Co-Investment Holdings III, LLC (9.90%) and 4 more
1,955,1059.90%13G (passive) amendmentMar 31, 2026
Robert Atchinson
Joint filing with Adage Capital Management, L.P. (6.81%), Phillip Gross (6.81%)
1,899,4956.81%13G (passive) amendmentJun 30, 2026
Joseph Edelman
Joint filing with Perceptive Advisors LLC (5.50%), Perceptive Life Sciences Master Fund, Ltd. (5.50%)
1,447,7825.50%13G (passive) amendmentMar 31, 2026
Millennium Group Management LLC
Joint filing with Israel A. Englander (5.10%), Millennium Management LLC (5.10%)
1,347,1305.10%13G (passive)May 18, 2026
Ikarian Capital, LLC
Joint filing with Neil Shahrestani (6.70%)
1,145,1006.70%13G (passive) amendmentMar 31, 2026
VHCP Management III, LLC
Joint filing with Bong Y. Koh (9.90%), Nimish Shah (9.90%) and 4 more
692,9599.90%13G (passive) amendmentDec 31, 2025
Janus Henderson Group PLC623,7339.99%13G (passive)Nov 28, 2025
Easton Jeff
Joint filing with Lind Global Fund II LP (6.62%), Lind Global Partners II LLC (6.62%)
442,4806.62%13G (passive) amendmentDec 31, 2025
Point72 Asset Management, L.P.
Joint filing with Point72 Capital Advisors, Inc. (6.80%), Steven A. Cohen (6.80%)
423,4156.80%13G (passive) amendmentDec 31, 2025
RTW Investments, LP
Joint filing with Roderick Wong, M.D. (9.99%)
418,4409.99%13G (passive)Mar 31, 2025

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of TENXValueChange% of portfolio
FMR LLC3,942,37310.53%$57.36M+3,619,7730.00%
Vivo Capital, LLC2,500,0006.68%$36.38M+2,291,6673.32%
BlackRock, Inc.1,727,9884.62%$25.14M+1,711,0110.00%
Perceptive Advisors LLC1,700,0004.54%$24.74M+252,2180.37%
Vanguard Capital Management LLC1,147,1213.07%$16.69M+883,7000.00%
Millennium Management LLC876,2302.34%$12.75M+342,3410.00%
Ikarian Capital, LLC787,6002.10%$11.46M−230,0001.23%
Candriam S.C.A.749,5882.00%$10.90MNew0.05%
Citadel Advisors LLC728,5611.95%$10.60M+576,0450.00%
Rtw Investments, LP696,5701.86%$10.14M+326,3240.09%
Stonepine Capital Management, LLC660,0001.76%$9.60M−315,2005.42%
Geode Capital Management, LLC639,5371.71%$9.31M+570,3770.00%
Price T Rowe Associates Inc /Md/607,6601.62%$8.84M−2,343,4560.00%
Marshall Wace, Llp585,5781.56%$8.52M+233,0060.01%
Braidwell LP584,4121.56%$8.50MNew0.31%
Point72 Asset Management, L.P.556,7611.49%$8.10M+22,7960.01%
Velan Capital Investment Management LP549,9851.47%$8.00M−33,3484.87%
Adage Capital Partners Gp, L.L.C.540,1261.44%$7.86M–0.01%
Woodline Partners LP531,2541.42%$7.73M+207,3430.02%
State Street Corp510,8141.36%$7.43M+481,8240.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202611130M81.1%45 / 3914 / 1319M8M
Q1 20268022M57.9%34 / 266 / 115M0M
Q4 2025497M18.9%20 / 123 / 53M0M
Q3 2025345M12.6%11 / 92 / 33M0M
Q2 2025262M6.0%3 / 64 / 00M0M
Q1 2025232M5.4%4 / 53 / 21M0M
Q4 2024211M3.6%7 / 23 / 50M0M
Q3 2024191M3.3%13 / 31 / 41M0M
Q2 2024110M0.1%4 / 21 / 20M0M
Q1 202490M0.0%9 / 00 / 00M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

75 funds held TENX in Q2 2026, 59% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of TENXValue% of fundAs of
Vanguard Total Stock Market Index Fund852,2592.28%$12.40M0.00%Jun 30, 2026
iShares Russell 2000 ETF648,7821.73%$9.44M0.01%Jun 30, 2026
T. Rowe Price Health Sciences Fund, Inc.445,9761.19%$6.49M0.05%Jun 30, 2026
Fidelity Advisor Biotechnology Fund445,1001.19%$6.10M0.28%Jul 31, 2026
Nuveen Quant Small Cap Equity Fund432,2001.15%$5.92M0.15%Jul 31, 2026
Fidelity Small Cap Discovery Fund335,0160.90%$4.59M0.20%Jul 31, 2026
Fidelity Series Small Cap Discovery Fund299,1000.80%$4.10M0.21%Jul 31, 2026
Fidelity Series Small Cap Core Fund282,4000.75%$3.87M0.25%Jul 31, 2026
Vanguard Extended Market Index Fund277,8500.74%$4.04M0.00%Jun 30, 2026
Fidelity Small Cap Index Fund275,7030.74%$3.78M0.01%Jul 31, 2026
iShares Russell 2000 Value ETF228,2710.61%$3.32M0.02%Jun 30, 2026
BNY Mellon Small/Mid Cap Growth Fund125,3620.33%$1.82M0.21%Jun 30, 2026
iShares Micro-Cap ETF83,9070.22%$1.22M0.08%Jun 30, 2026
Strategic Advisers Fidelity U.S. Total Stock Fund76,9410.21%$913.29K0.00%May 31, 2026
Dimensional U.S. Small Cap ETF68,6840.18%$940.97K0.01%Jul 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Christopher Thomas GiordanoCEO, Director22,1740.06%Sep 15, 2026
Stuart RichChief Medical Officer, Director12,6540.03%Jan 13, 2026
Thomas R. Staab IiChief Financial Officer15,6750.04%Sep 15, 2026
Thomas McGauleyInterim CFO8,0000.02%Feb 3, 2026
Declan DooganDirector55,2740.15%Sep 17, 2026
Michael H. DavidsonDirector2,8810.01%Jan 13, 2026
Gerald T. ProehlDirector1,6670.00%Jan 13, 2026
June Sherie AlmenoffDirector3,9860.01%Jan 13, 2026
Robyn HunterDirector0–Jan 13, 2026
ADAR1 Capital Management, LLC10% owner7,447,00019.90%Oct 21, 2026
Daniel Schneeberger10% owner5,624,15115.03%Oct 21, 2026
Investments LP Dellora–351,0710.94%Mar 12, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
ADAR1 Capital Management, LLC
10% owner
Oct 21, 2026Buy+331,979$1.66$550.69K7,447,000
ADAR1 Capital Management, LLC
10% owner
Oct 20, 2026Buy+254,342$1.60$405.73K7,115,021
ADAR1 Capital Management, LLC
10% owner
Oct 19, 2026Buy+336,528$1.51$507.01K6,860,679
Declan Doogan
Director
Sep 16, 2026Buy+53,000$1.92$101.76K55,274
Christopher Thomas Giordano
CEO, Director
Sep 15, 2026Buy+4,850$1.82$8.83K22,174
Christopher Thomas Giordano
CEO, Director
Sep 11, 2026Buy+6,000$1.88$11.28K17,324
Thomas R. Staab Ii
Chief Financial Officer
Sep 11, 2026Buy+5,675$1.94$11.01K15,675
ADAR1 Capital Management, LLC
10% owner
Sep 3, 2026Buy+900,000$1.78$1.60M6,524,151
Daniel Schneeberger
10% owner
Sep 2, 2026Buy+187,704$1.80$337.87K5,624,151
Daniel Schneeberger
10% owner
Sep 1, 2026Buy+179,058$1.80$322.30K5,436,447
Daniel Schneeberger
10% owner
Aug 31, 2026Buy+403,571$1.79$722.39K5,257,389
Daniel Schneeberger
10% owner
Aug 24, 2026Buy+107,374$1.75$187.90K4,853,818
Daniel Schneeberger
10% owner
Aug 21, 2026Buy+716,369$1.77$1.27M4,746,444
Daniel Schneeberger
10% owner
Aug 20, 2026Buy+202,124$1.78$359.78K4,030,075
Christopher Thomas Giordano
CEO, Director
Jul 13, 2026Option exercise+8,500$5.94$50.49K11,324
Christopher Thomas Giordano
CEO, Director
Jul 13, 2026Option exercise+219$3.55$7772,824
Thomas R. Staab Ii
Chief Financial Officer
May 11, 2026Award+10,000––10,000
Stuart Rich
Chief Medical Officer, Director
Dec 9, 2025Buy+2,500$10.22$25.55K5,266
Stuart Rich
Chief Medical Officer, Director
Dec 8, 2025Buy+2,500$10.10$25.25K5,000
Stuart Rich
Chief Medical Officer, Director
Dec 4, 2025Buy+2,500$9.20$23.00K2,500
Stuart Rich
Chief Medical Officer, Director
Dec 3, 2025Buy+1,500$9.08$13.62K2,766
Stuart Rich
Chief Medical Officer, Director
Dec 2, 2025Buy+1,000$9.01$9.01K1,266
Christopher Thomas Giordano
CEO, Director
Nov 20, 2025Buy+538$7.59$4.08K2,605
Christopher Thomas Giordano
CEO, Director
Nov 19, 2025Buy+455$7.51$3.42K2,067
Christopher Thomas Giordano
CEO, Director
Nov 18, 2025Buy+1,612$7.75$12.49K1,612
June Sherie Almenoff
Director
Nov 18, 2025Buy+1,900$7.52$14.29K1,993
June Sherie Almenoff
Director
Nov 18, 2025Buy+1,900$7.52$14.29K1,993
June Sherie Almenoff
Director
Nov 17, 2025Buy+93$7.15$66593
June Sherie Almenoff
Director
Nov 17, 2025Buy+93$7.15$66593
Thomas McGauley
Interim CFO
Nov 17, 2025Buy+2,000$7.34$14.68K2,000
Thomas McGauley
Interim CFO
Nov 17, 2025Buy+1,000$7.35$7.35K1,000
Thomas McGauley
Interim CFO
Nov 17, 2025Buy+5,000$7.23$36.15K5,000
Gerald T. Proehl
Director
Aug 8, 2024Buy+1,666––1,667
Michael H. Davidson
Director
Aug 8, 2024Buy+2,500––2,881
Stuart Rich
Chief Medical Officer, Director, 10% owner
Sep 21, 2022Gift+1,909,585––1,909,585
Stuart Rich
Chief Medical Officer, Director, 10% owner
Sep 21, 2022Gift−1,909,585––424,347
Declan Doogan
Director, 10% owner
Aug 11, 2022Gift−567,871––0
Declan Doogan
Director, 10% owner
Aug 11, 2022Gift+567,871––3,637,871
Stuart Rich
Chief Medical Officer, Director, 10% owner
Nov 29, 2021Gift−1,909,585––0
Stuart Rich
Chief Medical Officer, Director, 10% owner
Nov 29, 2021Gift+1,909,585––1,909,585
Stuart Rich
Chief Medical Officer, Director, 10% owner
Oct 12, 2021Gift−1,909,585––2,333,932
Stuart Rich
Chief Medical Officer, Director, 10% owner
Oct 12, 2021Gift+1,909,585––1,909,585
Declan Doogan
Director, 10% owner
Jun 30, 2021Gift−567,871––2,502,129
Stuart Rich
Chief Medical Officer, Director, 10% owner
Jun 11, 2021Option exercise+3,581,000––4,243,517
Michael H. Davidson
Director
Jun 11, 2021Award+512,000––606,645
Declan Doogan
Director, 10% owner
Jun 11, 2021Option exercise+3,070,000––3,637,871
Stuart Rich
Chief Medical Officer
Jan 15, 2021Award+3,581––3,581
Stuart Rich
Chief Medical Officer
Jan 15, 2021Award+662,517––662,517
Capital Master Fund Ltd. Armistice
Director, 10% owner
Sep 8, 2020Buy+8,543$1.46$12.47K2,019,995
Capital Master Fund Ltd. Armistice
Director, 10% owner
Sep 8, 2020Buy+0––2,019,995
Capital Master Fund Ltd. Armistice
Director, 10% owner
Sep 4, 2020Buy+0––2,011,452
Capital Master Fund Ltd. Armistice
Director, 10% owner
Sep 4, 2020Buy+23,457$1.41$33.07K2,011,452
Armistice Capital, Llc
Director, 10% owner
Sep 3, 2020Buy+0––1,987,995
Armistice Capital, Llc
Director, 10% owner
Sep 3, 2020Buy+36,000$1.39$50.04K1,987,995
Armistice Capital, Llc
Director, 10% owner
Sep 2, 2020Buy+20,000$1.47$29.40K1,951,995
Armistice Capital, Llc
Director, 10% owner
Sep 2, 2020Buy+0––1,951,995
Armistice Capital, Llc
Director, 10% owner
Sep 1, 2020Buy+0––1,931,995
Armistice Capital, Llc
Director, 10% owner
Sep 1, 2020Buy+30,000$1.46$43.80K1,931,995
Armistice Capital, Llc
Director, 10% owner
Aug 31, 2020Buy+20,000$1.45$29.00K1,901,995
Armistice Capital, Llc
Director, 10% owner
Aug 31, 2020Buy+0––1,901,995

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
16.33%
6M shares short
Days to cover
3.2
At 2M shares a day
Change since last report
-19.5%
From 7M shares
Short volume, 20 days
52.2%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Tenax Therapeutics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 466,064 shares on Sep 2, 2026 over the last 90 days.

See a number that looks wrong?